These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 4578655
1. Difficulties designing clinical trials as exemplified by a phase 2 drug evaluation of 5(3,3-bis(2-chloroethyl)-1-triazenol)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in patients with disseminated breast cancer. Ahmann DL, Bisel HF, Hahn RG. Cancer Res; 1973 Jul; 33(7):1707-10. PubMed ID: 4578655 [No Abstract] [Full Text] [Related]
2. A phase 2 evaluation of 1-(2-chloroethyl)-3-(4- methylcyclohexyl)-1-nitrosourea (NSC 95441) in patients with advanced breast cancer. Ahmann DL, Bisel HF, Hahn RG. Cancer Res; 1974 Jan; 34(1):27-30. PubMed ID: 4809462 [No Abstract] [Full Text] [Related]
3. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma. Ahmann DL, Hahn RG, Bisel HF. Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592 [No Abstract] [Full Text] [Related]
4. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma. Ahmann DL, Hahn RG, Bisel HF. Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357 [No Abstract] [Full Text] [Related]
5. Combination chemotherapy with CCNU (NSC-79037) and 5-(3, 3-bis(2-chloroethyl)-1-triazeno)-imidazole-4-carboxamide (NSC-82196). Chang H, Freireich EJ, Khaliq A, Einhorn L, Gottlieb JA. Cancer Chemother Rep; 1975 Mar; 59(4):769-71. PubMed ID: 1100230 [No Abstract] [Full Text] [Related]
6. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037). Einhorn LH, Livingston RB, Gottlieb JA. Cancer Chemother Rep; 1973 Mar; 57(4):437-45. PubMed ID: 4586951 [No Abstract] [Full Text] [Related]
8. 5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy. Komp DM, Land VJ, Nitschke R, Cangir A, Dyment P. Cancer Chemother Rep; 1975 Nov; 59(2 Pt 1):371-6. PubMed ID: 1097094 [No Abstract] [Full Text] [Related]
9. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study. Hoogstraten B, Gottlieb JA, Caoili E, Tucker WG, Talley RW, Haut A. Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783 [No Abstract] [Full Text] [Related]
16. Second-line chemotherapy with tauromustine in metastatic breast cancer in postmenopausal women: a phase II study. Ernst P, Balslev I, Mouridsen HT. Cancer Treat Rep; 1987 Oct; 71(10):987-8. PubMed ID: 3652062 [No Abstract] [Full Text] [Related]
17. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity. Schein PS, McMenamin MG, Anderson T. Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476 [No Abstract] [Full Text] [Related]